Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 15, 2019
Follow-Up of Patients With Complete Remission of Locally Advanced Basal Cell Carcinoma After Vismodegib Discontinuation: A Multicenter French Study of 116 Patients
Florian Herms, Jerome Lambert, Jean-Jacques Grob, et al.
Blood Advances
|
October 9, 2021
Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML
Juliette Lambert, Jerome Lambert, Xavier Thomas, et al.
British Journal of Haematology
|
November 13, 2023
Low non-relapse mortality and good haematological and renal responses after autologous haematopoietic stem cell transplantation in multiple myeloma patients with renal insufficiency at transplant: A prospective Société Francophone de Greffe de Moelle-Thérapie Cellulaire observational study
Laurent Garderet, Hafida Ouldjeriouat, Mohamed-Amine Bekadja, et al.
Haematologica
|
October 16, 2012
Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemia
Florence Nguyen-Khac, Jerome Lambert, Elise Chapiro, et al.
Blood
|
March 24, 2025
Daratumumab-Bortezomib-Thalidomide-Dexamethasone for Newly Diagnosed Myeloma: CASSIOPEIA Minimal Residual Disease Results
Jill Corre, Laure Vincent, Philippe Moreau, et al.
Blood Advances
|
September 18, 2025
Poor Outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study
Sarah Cayla, Lionel Karlin, Jerome Lambert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 26, 2022
Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell Carcinoma
Andrey A Yurchenko, Oltin T Pop, Meriem Ighilahriz, et al.
Journal of Neurointerventional Surgery
|
August 27, 2025
Glenzocimab for reperfusion in the setting of endovascular therapy for brain infarction: GREEN study
Mikaël Mazighi, Jerome Lambert, Benjamin Gory, et al.
Blood
|
January 22, 2025
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone Induction in Newly Diagnosed Myeloma: Analysis of the MIDAS Trial
Aurore Perrot, Cyrille Touzeau, Jerome Lambert, et al.
Nature Medicine
|
June 3, 2024
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial
Xavier Leleu, Cyrille Hulin, Jerome Lambert, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 15, 2019
Follow-Up of Patients With Complete Remission of Locally Advanced Basal Cell Carcinoma After Vismodegib Discontinuation: A Multicenter French Study of 116 Patients
Florian Herms, Jerome Lambert, Jean-Jacques Grob, et al.
Blood Advances
|
October 9, 2021
Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML
Juliette Lambert, Jerome Lambert, Xavier Thomas, et al.
British Journal of Haematology
|
November 13, 2023
Low non-relapse mortality and good haematological and renal responses after autologous haematopoietic stem cell transplantation in multiple myeloma patients with renal insufficiency at transplant: A prospective Société Francophone de Greffe de Moelle-Thérapie Cellulaire observational study
Laurent Garderet, Hafida Ouldjeriouat, Mohamed-Amine Bekadja, et al.
Haematologica
|
October 16, 2012
Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemia
Florence Nguyen-Khac, Jerome Lambert, Elise Chapiro, et al.
Blood
|
March 24, 2025
Daratumumab-Bortezomib-Thalidomide-Dexamethasone for Newly Diagnosed Myeloma: CASSIOPEIA Minimal Residual Disease Results
Jill Corre, Laure Vincent, Philippe Moreau, et al.
Blood Advances
|
September 18, 2025
Poor Outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study
Sarah Cayla, Lionel Karlin, Jerome Lambert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 26, 2022
Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell Carcinoma
Andrey A Yurchenko, Oltin T Pop, Meriem Ighilahriz, et al.
Journal of Neurointerventional Surgery
|
August 27, 2025
Glenzocimab for reperfusion in the setting of endovascular therapy for brain infarction: GREEN study
Mikaël Mazighi, Jerome Lambert, Benjamin Gory, et al.
Blood
|
January 22, 2025
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone Induction in Newly Diagnosed Myeloma: Analysis of the MIDAS Trial
Aurore Perrot, Cyrille Touzeau, Jerome Lambert, et al.
Nature Medicine
|
June 3, 2024
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial
Xavier Leleu, Cyrille Hulin, Jerome Lambert, et al.
Page
of 3